157 related articles for article (PubMed ID: 4260802)
1. Mode of action of L-DOPA on central noradrenaline mechanisms.
Andén NE; Engel J; Rubenson A
Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):1-10. PubMed ID: 4260802
[No Abstract] [Full Text] [Related]
2. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
Andén NE; Fuxe K
Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
[TBL] [Abstract][Full Text] [Related]
3. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
Andén NE; Engel J
Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
[No Abstract] [Full Text] [Related]
4. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
[No Abstract] [Full Text] [Related]
5. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
Andén NE; Strömbom U
Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
[No Abstract] [Full Text] [Related]
6. The effects of L-3,4-dihydroxyphenylalanine on spinal reflex activity.
Baker RG; Anderson EG
J Pharmacol Exp Ther; 1970 May; 173(1):212-23. PubMed ID: 5442299
[No Abstract] [Full Text] [Related]
7. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
Vetulani J; Reichenberg K
Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
[No Abstract] [Full Text] [Related]
8. A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.
Commissiong JW; Sedgwick EM
Br J Pharmacol; 1974 Mar; 50(3):365-74. PubMed ID: 4850262
[TBL] [Abstract][Full Text] [Related]
9. Production of a stereotyped behaviour in rats by dopamine in the absence of noradrenaline.
Scheel-Krüger J; Randrup A
Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:61. PubMed ID: 5630954
[No Abstract] [Full Text] [Related]
10. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
Anderson EG; Baker RG; Banna NR
J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
[No Abstract] [Full Text] [Related]
11. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
Landsberg L; Bruno SJ
Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
[No Abstract] [Full Text] [Related]
12. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
[No Abstract] [Full Text] [Related]
13. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
[No Abstract] [Full Text] [Related]
14. Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin.
Chruściel TL; Herman ZS
Psychopharmacologia; 1969; 14(2):124-34. PubMed ID: 5350621
[No Abstract] [Full Text] [Related]
15. Localization of dopamine and norepinephrine in the medial basal hypothalamus of the rat.
Kavanagh A; Weisz J
Neuroendocrinology; 1973-1974; 13(4):201-12. PubMed ID: 4779325
[No Abstract] [Full Text] [Related]
16. The postnatal ontogeny of monoamine-containing neurones in the central nervous system of the albino rat.
Loizou LA
Brain Res; 1972 May; 40(2):395-418. PubMed ID: 4537284
[No Abstract] [Full Text] [Related]
17. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
Svensson TH
Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
[No Abstract] [Full Text] [Related]
18. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
Jonsson G; Sachs C
Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
[No Abstract] [Full Text] [Related]
19. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
Farnebo LO; Fuxe K; Goldstein M; Hamberger B; Ungerstedt U
Eur J Pharmacol; 1971 Sep; 16(1):27-38. PubMed ID: 5157529
[No Abstract] [Full Text] [Related]
20. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
Corrodi H; Fuxe K
Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
